{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:29:51Z","timestamp":1780612191996,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Department of Radiation Oncology"},{"name":"Rocky Mountain Cancer Centers"},{"DOI":"10.13039\/100008067","name":"Genomic Health, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008067","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.adro.2020.10.020","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T10:02:32Z","timestamp":1604224952000},"page":"100607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay"],"prefix":"10.1016","volume":"6","author":[{"given":"Rachel Y.","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Antell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly A.","family":"Nowels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon P.","family":"Tole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Baehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2020.10.020_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00000658-198008000-00001","article-title":"Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons","volume":"192","author":"Rosner","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2020.10.020_bib2","first-page":"438","article-title":"Breast cancer statistics, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2020.10.020_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","article-title":"Risk factors for breast cancer in women with proliferative breast disease","volume":"312","author":"Dupont","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2020.10.020_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y","article-title":"Intraductal carcinoma of the breast: follow-up after biopsy only","volume":"49","author":"Page","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2020.10.020_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9610(03)00265-4","article-title":"The University of Southern California\/Van Nuys prognostic index for ductal carcinoma in situ of the breast","volume":"186","author":"Silverstein","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.adro.2020.10.020_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jncimonographs\/lgq040","article-title":"Choosing treatment for patients with ductal carcinoma in situ: Fine tuning the University of Southern California\/Van Nuys Prognostic Index","volume":"2010","author":"Silverstein","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.adro.2020.10.020_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006437902770","article-title":"Application of the Van Nuys Prognostic Index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: Practical considerations","volume":"61","author":"de Mascarel","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.adro.2020.10.020_bib9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/bjs.4051","article-title":"Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery","volume":"90","author":"Boland","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.adro.2020.10.020_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1524-4741.2007.00443.x","article-title":"The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis","volume":"13","author":"Asjoe","year":"2007","journal-title":"Breast J"},{"key":"10.1016\/j.adro.2020.10.020_bib11","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/cncr.23089","article-title":"An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ","volume":"110","author":"MacAusland","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2020.10.020_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7819-6-61","article-title":"The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ","volume":"6","author":"Gilleard","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/2193-1801-3-405","article-title":"Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?","volume":"3","author":"Kim","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.adro.2020.10.020_bib14","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib15","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1200\/JCO.2010.32.3717","article-title":"Nomogram for risk of relapse after breast-conserving surgery in ductal carcinoma in situ","volume":"29","author":"Mazouni","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib16","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1200\/JCO.2010.32.6850","article-title":"Inclusion of tumor biology molecular markers to improve the ductal carcinoma in situ ipsilateral breast tumor recurrence nomogram predictability","volume":"29","author":"Ballehaninna","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.2011.36.4976","article-title":"Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision","volume":"30","author":"Yi","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0000000000000025","article-title":"Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram","volume":"20","author":"Sweldens","year":"2014","journal-title":"Cancer J"},{"key":"10.1016\/j.adro.2020.10.020_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.clon.2014.08.004","article-title":"Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast","volume":"26","author":"Wang","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2020.10.020_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2020.10.020_bib21","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biologic signature for breast ductal carcinoma in situ to predict radiation therapy (RT) benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2020.10.020_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","article-title":"A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone","volume":"152","author":"Rakovitch","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.adro.2020.10.020_bib23","article-title":"Refined estimates of local recurrence risks and the impact of the DCIS score adjusting for clinico-pathological features: Meta-analysis of E5194 and Ontario DCIS cohort studies. 2017 ASCO","author":"Rakovitch","year":"2017","journal-title":"Annual Meeting"},{"key":"10.1016\/j.adro.2020.10.020_bib25","series-title":"R: A language and environment for statistical computing","year":"2018"},{"key":"10.1016\/j.adro.2020.10.020_bib26","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.adro.2020.10.020_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","article-title":"Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: Intraductal carcinoma","volume":"86","author":"Fisher","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2020.10.020_bib28","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"Bijker","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1200\/JCO.2007.12.7969","article-title":"Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast","volume":"26","author":"Holmberg","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib31","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ijrobp.2012.07.011","article-title":"Low-risk breast ductal carcinoma in situ (DCIS): Results from the Radiation Therapy Oncology Group 9804 phase 3 trial","volume":"84","author":"McCormick","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2020.10.020_bib32","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/jnci\/djt256","article-title":"Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?","volume":"105","author":"Punglia","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2020.10.020_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.adro.2020.10.020_bib34","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2020.10.020_bib35","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jnci\/djt096","article-title":"Modeling the effectiveness of initial management strategies for ductal carcinoma in situ","volume":"105","author":"Soeteman","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2020.10.020_bib36","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2015.65.1869","article-title":"Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: A population-based longitudinal cohort study","volume":"34","author":"Sagara","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2214\/ajr.168.2.9016233","article-title":"Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ","volume":"168","author":"Liberman","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.adro.2020.10.020_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2214\/AJR.06.1281","article-title":"Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence","volume":"189","author":"Pinsky","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.adro.2020.10.020_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2014.06.011","article-title":"Radiotherapy in DCIS, an underestimated benefit?","volume":"112","author":"Cutuli","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2020.10.020_bib41","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canrad.2013.01.011","article-title":"Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases","volume":"17","author":"Cutuli","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.adro.2020.10.020_bib43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/jso.23933","article-title":"The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score result","volume":"111","author":"Alvarado","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.adro.2020.10.020_bib44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1245\/s10434-016-5583-7","article-title":"Clinical utility of the 12-gene DCIS Score assay: impact on radiotherapy recommendations for patients with ductal carcinoma in situ","volume":"24","author":"Manders","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109420303109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109420303109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:38:14Z","timestamp":1762529894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109420303109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2452109420303109"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2020.10.020","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2020.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100607"}}